MarketCap
Facebook
X
TelegramAnnual report 2025
added 04-18-2026
QIAGEN N.V. Long Term Debt Current 2011-2026 | QGEN
Annual Long Term Debt Current QIAGEN N.V.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | 23.4 M | 18.7 M | 503 M | - | - | - | 131 M | 207 K | 948 K | 1.62 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 503 M | 207 K | 97 M |
Long Term Debt Current of other stocks in the Diagnostics research industry
| Issuer | Long Term Debt Current | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
2.18 M | - | -6.23 % | $ 30.6 M |  Germany |
|
Akumin
AKU
|
17.2 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Accelerate Diagnostics
AXDX
|
829 K | - | -61.36 % | $ 2.46 M |  USA |
 |
Co-Diagnostics
CODX
|
662 K | $ 1.67 | - | $ 2.22 M | USA |
 |
Aspira Women's Health
AWH
|
202 K | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
518 K | - | -13.05 % | $ 7.29 M | USA |
 |
Castle Biosciences
CSTL
|
1.66 M | $ 25.26 | 3.27 % | $ 702 M | USA |
 |
Chembio Diagnostics
CEMI
|
915 K | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
264 K | - | - | $ 9.42 M |  Israel |
 |
CareDx, Inc
CDNA
|
6.52 M | $ 21.52 | 1.37 % | $ 1.15 B | USA |
 |
DermTech
DMTK
|
3.07 M | - | -11.32 % | $ 2.94 M | USA |
 |
Enzo Biochem
ENZ
|
841 K | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
33.6 M | - | - | $ 19.8 B | USA |
 |
Illumina
ILMN
|
79 M | $ 127.89 | 0.01 % | $ 20.3 B | USA |
 |
Fulgent Genetics
FLGT
|
1.44 M | $ 16.19 | -0.74 % | $ 490 M | USA |
 |
Global Cord Blood Corporation
CO
|
147 K | - | - | $ 399 M |  China |
 |
Genetic Technologies Limited
GENE
|
264 K | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
21.5 M | - | 0.12 % | $ 80.1 M | China |
 |
Charles River Laboratories International
CRL
|
57.7 M | $ 172.96 | 1.88 % | $ 8.57 B | USA |
 |
Guardant Health
GH
|
27.7 M | $ 90.69 | 2.0 % | $ 11.4 B | USA |
 |
Lantheus Holdings
LNTH
|
3.8 M | $ 84.36 | 0.04 % | $ 5.69 B | USA |
 |
Medpace Holdings
MEDP
|
23.2 M | $ 416.53 | 1.46 % | $ 12 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
475 K | - | -20.0 % | $ 1.06 M | USA |
 |
Heska Corporation
HSKA
|
2.94 M | - | - | $ 1.31 B | USA |
 |
Interpace Biosciences
IDXG
|
431 K | $ 2.0 | 1.27 % | $ 8.85 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
241 M | $ 27.72 | 0.91 % | $ 20 B |  Niderland |
 |
Motus GI Holdings
MOTS
|
169 K | - | -34.28 % | $ 263 K | Israel |
 |
Senseonics Holdings
SENS
|
496 K | $ 7.07 | 0.21 % | $ 295 M | USA |
 |
Neogen Corporation
NEOG
|
5.64 M | $ 9.6 | 0.58 % | $ 2.08 B | USA |
 |
Soleno Therapeutics
SLNO
|
726 K | $ 52.74 | 0.04 % | $ 2.68 B | USA |
 |
Biomerica
BMRA
|
358 K | $ 2.17 | 1.4 % | $ 4.98 M | USA |
 |
National Research Corporation
NRC
|
451 K | $ 17.26 | 0.17 % | $ 386 M | USA |
 |
ICON Public Limited Company
ICLR
|
24.3 M | $ 102.05 | -0.12 % | $ 8.42 B |  Irlanda |
 |
Laboratory Corporation of America Holdings
LH
|
191 M | $ 265.38 | 0.62 % | $ 22.1 B | USA |
 |
Thermo Fisher Scientific
TMO
|
275 M | $ 470.88 | 0.28 % | $ 178 B | USA |
 |
Celcuity
CELC
|
54 K | $ 125.51 | 3.7 % | $ 5.87 B | USA |
 |
OpGen
OPGN
|
174 K | - | -16.95 % | $ 1.54 M | USA |
 |
NeoGenomics
NEO
|
4.78 M | $ 8.43 | 1.69 % | $ 1.08 B | USA |
 |
Twist Bioscience Corporation
TWST
|
13.8 M | $ 60.75 | -0.31 % | $ 3.63 B | USA |
 |
Myriad Genetics
MYGN
|
6.9 M | $ 4.79 | 0.1 % | $ 444 M | USA |
 |
Natera
NTRA
|
7.64 M | $ 206.25 | 1.23 % | $ 20.3 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
174 M | $ 197.24 | 0.52 % | $ 21.9 B | USA |
 |
Invitae Corporation
NVTA
|
14.6 M | - | - | $ 21.2 M | USA |
 |
PerkinElmer
PKI
|
589 M | - | -0.91 % | $ 14.7 B | USA |